CSIMarket
 


Precipio inc   (NASDAQ: PRPO)
Other Ticker:  
 

Precipio Inc 's Leverage Ratio

PRPO's quarterly Leverage Ratio and Total Liabilities, Equity growth

 


Due to repayements of liabilities of -1.61% Precipio Inc improved Leverage Ratio in forth quarter 2024 to 0.36, below the company's average Leverage Ratio.

Within Laboratory Analytical Instruments industry in the forth quarter 2024, 10 other companies have achieved lower Leverage Ratio than Precipio Inc in the Q4 2024. While Leverage Ratio total ranking has improved so far in the forth quarter 2024 to 700, from total ranking in the third quarter 2024 at 771 .

Explain Leverage Ratio?
How much Total Liabilitiess PRPO´s has?


PRPO Leverage Ratio (Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q3
(Dec 31 2023)
Q4
Y / Y Equity Change -16.18 % -8.13 % -14.02 % -10.2 % -11.84 %
Y / Y Total Liabilities Change 35.27 % -22.82 % -8.3 % -29.27 % -31.98 %
Leverage Ratio MRQ 0.36 0.37 0.38 0.26 0.22
PRPO's Total Ranking # 700 # 771 # 505 # 335 # 345
Seq. Equity Change 1.25 % -1.4 % -5.16 % -11.47 % 10.98 %
Seq. Total Liabilities Change -1.61 % -4.62 % 36.98 % 5.23 % -43.87 %



Leverage Ratio forth quarter 2024 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 11
Healthcare Sector # 309
Overall Market # 700


Leverage Ratio Statistics
High Average Low
3.58 0.92 0.2
(Dec 31 2014)   (Sep 30 2021)




Financial Statements
Precipio Inc 's Equity $ 12 Millions Visit PRPO's Balance sheet
Precipio Inc 's Total Liabilities $ 4 Millions Visit PRPO's Balance sheet
Source of PRPO's Sales Visit PRPO's Sales by Geography


Cumulative Precipio Inc 's Leverage Ratio

PRPO's Leverage Ratio for the trailling 12 Months

PRPO Leverage Ratio

(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
Y / Y Equity TTM Growth -12.23 % -11.13 % -16.87 % -21.78 % -28.01 %
Y / Y Total Liabilities TTM Growth -10.61 % -22.86 % -13.22 % -11.25 % -6.99 %
Leverage Ratio TTM 0.34 0.31 0.32 0.32 0.34
Total Ranking TTM # 13 # 9 # 10 # 1 # 2
Seq. Equity TTM Growth -4.55 % -2.02 % -3.64 % -2.6 % -3.36 %
Seq. Total Liabilities TTM Growth 7.25 % -7.71 % -2.41 % -7.46 % -7.45 %


On the trailing twelve months basis Despite of the repayements of liabilities of -1.61% in the trailing twelve months ending in Q4 2024, Leverage Ratio improved to 0.34, below Precipio Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Laboratory Analytical Instruments industry PRPO recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has deteriorated during the twelve months ending in the Q4 2024, compared to the prior period, from 9 to 13.

Explain Leverage Ratio?
How much Total Liabilitiess PRPO´s has?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 0
Healthcare Sector # 3
Within the Market # 13


trailing twelve months Leverage Ratio Statistics
High Average Low
88.45 2.49 0.01
(Sep 30 2017)   (Mar 31 2022)




Companies with similar Leverage Ratio in the quarter ending Dec 31 2024, within Laboratory Analytical Instruments Industry Leverage RatioDec 31 2024 MRQ Total LiabilitiesDec 31 2024 MRQ Equity
Agilent Technologies inc   0.98 $ 5,887.000  Millions$ 6,027.000  Millions
Avantor Inc   0.94 $ 5,600.500  Millions$ 5,956.700  Millions
Harvard Bioscience Inc   0.94 $ 59.498  Millions$ 63.340  Millions
Revvity Inc   0.62 $ 4,725.604  Millions$ 7,666.874  Millions
Bio rad Laboratories Inc   0.42 $ 2,753.100  Millions$ 6,569.300  Millions
Precipio inc   0.36 $ 4.345  Millions$ 12.094  Millions
Rapid Micro Biosystems Inc   0.30 $ 22.817  Millions$ 75.352  Millions
Standard Biotools Inc   0.30 $ 140.622  Millions$ 471.722  Millions
Scientific Industries Inc   0.27 $ 2.441  Millions$ 9.119  Millions
Cytek Biosciences Inc   0.24 $ 96.211  Millions$ 395.737  Millions
Quanterix Corporation  0.23 $ 76.495  Millions$ 330.038  Millions
Eyepoint Pharmaceuticals Inc   0.18 $ 60.106  Millions$ 336.501  Millions
10x Genomics Inc   0.17 $ 122.662  Millions$ 710.134  Millions
Nautilus Biotechnology Inc   0.16 $ 34.013  Millions$ 208.730  Millions
Astrotech Corp  0.10 $ 2.907  Millions$ 28.094  Millions

Date modified: 2025-03-29T05:06:24+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com